Bifunctional Avidin with Covalently Modifiable Ligand Binding Site
2011

Bifunctional Avidin with Covalently Modifiable Ligand Binding Site

publication 10 minutes Evidence: moderate

Author Information

Author(s): Jenni Leppiniemi, Juha A. E. Määttä, Henrik Hammaren, Mikko Soikkeli, Mikko Laitaoja, Janne Jänis, Markku S. Kulomaa, Vesa P. Hytönen

Primary Institution: Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland

Hypothesis

Can a single point mutation in avidin create a covalently modifiable ligand binding site?

Conclusion

The engineered bifunctional avidin allows for the selective covalent linking of thiol-reactive molecules while maintaining some biotin-binding capability.

Supporting Evidence

  • The S16C mutation introduced a thiol group that can be covalently modified.
  • Binding assays showed that the modified avidin retained some affinity for biotin.
  • Fluorescent labels were successfully coupled to the modified avidin.

Takeaway

Scientists changed a part of a protein called avidin so it can stick to other things better, while still holding onto biotin a little bit.

Methodology

The study involved site-directed mutagenesis to introduce a cysteine residue into avidin, followed by biochemical assays to test binding properties.

Limitations

The study primarily focused on a specific mutation and its effects, which may not generalize to all avidin applications.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016576

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication